EX-10.22 11 dex1022.htm DEVELOPMENT & PRODUCTION AGREEMENT DATED 2/1/04 BETWEEN THE CO. & SIEGFRIED LTD. [********] Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the...Development and Production Agreement • May 5th, 2020 • Delaware
This DEVELOPMENT AND PRODUCTION Agreement (the “AGREEMENT”) is entered into as of the first (1st) day of February 2004 (the “EFFECTIVE DATE”) by and between SIEGFRIED and TARGACEPT.
DEVELOPMENT AND PRODUCTION AGREEMENTDevelopment and Production Agreement • December 11th, 2020 • Medirom Healthcare Technologies Inc. • Services-personal services • New York
This Development and Production Agreement (“Agreement”), which is effective as of August 4, 2020 (the “Effective Date”) is made and entered into by and between Matrix Industries, Inc., a Delaware USA corporation with a place of business at 1440 O’Brien Drive, Suite A-1, Menlo Park, California, USA 94025 (“Company”) and MEDIROM Healthcare Technologies Inc., a Japan corporation having a place of business at Tradepia Odaiba 16F, 2-3-1 Daiba, Minato-ku, Tokyo 135-0091, Japan (“Customer”). Company and Customer are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
DEVELOPMENT AND PRODUCTION AGREEMENT FOR ACTIVE PHARMACEUTICAL INGREDIENT betweenDevelopment and Production Agreement • May 21st, 2004 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New Jersey
SECOND AMENDMENT TO DEVELOPMENT AND PRODUCTION AGREEMENTDevelopment and Production Agreement • May 30th, 2023 • Medirom Healthcare Technologies Inc. • Services-personal services
This Second Amendment to the Development and Production Agreement dated August 4, 2020 (the “Second Amendment”) is made and entered into, effective as of December 8th, 2022 (the “Effective Date”), by and between Matrix Industries, Inc., a Delaware Corporation with a place of business at 1440 O’Brien Drive, Suite A-1, Menlo Park, California, USA 94025 (“Company”) and MEDIROM Healthcare Technologies Inc., a Japanese Joint Stock Corporation with a place of business at 2-3-1 Daiba, Minato-ku, Tokyo, Japan 135-0091 (“Customer”). Company and Customer are referred to collectively in this Agreement as the “Parties” or, individually, as a “Party”.
MINNETRONIX Incorporated MINNETRONIX DEVELOPMENT AND PRODUCTION AGREEMENTDevelopment and Production Agreement • October 17th, 2006 • Possis Medical Inc • Orthopedic, prosthetic & surgical appliances & supplies • Minnesota
MASTER DEVELOPMENT & PRODUCTION AGREEMENTDevelopment and Production Agreement • May 6th, 2015 • Enphase Energy, Inc. • Semiconductors & related devices • California
This Master Development and Production Agreement (the "Agreement") is entered into this 19 day of August, 2009 ("Effective Date") by and between Enphase Energy, Inc., having its principal place of business at 201 1st St., Suite 300, Petaluma, CA 94952 (“Buyer”) and Fujitsu Microelectronics America, Inc., having its principal place of business at 1250 E. Arques Ave., Sunnyvale, CA 94085 (“Seller”). In consideration of the mutual promises herein contained, the parties hereby agree as follows:
COAL MINE DEVELOPMENT AND PRODUCTION AGREEMENT FOR DETAILED EXPLORED BLOCKSDevelopment and Production Agreement • February 4th, 2014
